41
TITLE: How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to Consider
AUTHORS: Huub Schellekens; Sven Stegemann; Vera Weinstein; Jon S B de Vlieger; Beat Fluehmann; Stefan Muehlebach; Rogerio Gaspar; Vinod P Shah; Daan J A Crommelin;
PUBLISHED: 2014, SOURCE: AAPS JOURNAL, VOLUME: 16, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
42
TITLE: Preclinical development of siRNA therapeutics: Towards the match between fundamental science and engineered systems  Full Text
AUTHORS: Videira, M; Arranja, A; Rafael, D; Gaspar, R;
PUBLISHED: 2014, SOURCE: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, VOLUME: 10, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
43
TITLE: Regulatory Aspects of Oncologicals: Nanosystems Main Challenges
AUTHORS: Rogério S Gaspar; Helena F Florindo; Liana C Silva; Mafalda A Videira; Luísa L Corvo; Bárbara F Martins; Beatriz Silva-Lima;
PUBLISHED: 2014, SOURCE: Nano-Oncologicals - Advances in Delivery Science and Technology
INDEXED IN: CrossRef
44
TITLE: Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking
AUTHORS: Joao Conniot; Joana M Silva; Joana G Fernandes; Liana C Silva; Rogerio Gaspar; Steve Brocchini; Helena F Florindo; Teresa S Barata;
PUBLISHED: 2014, SOURCE: FRONTIERS IN CHEMISTRY, VOLUME: 2, ISSUE: NOV
INDEXED IN: Scopus WOS CrossRef
45
TITLE: Cervical abscess in an immunocompetent patient with Mycobacterium malmoense pulmonary disease  Full Text
AUTHORS: Duarte, JN; Marques, N; Barroso, L; Ramos, I; Sa, R; Sanz, D; Ferreira, A; da Cunha, S;
PUBLISHED: 2012, SOURCE: Oral and Maxillofacial Surgery, VOLUME: 16, ISSUE: 3
INDEXED IN: Scopus CrossRef
46
TITLE: Patentability and Intellectual Property Issues Related to Chitosan-Based Biopharmaceutical Products
AUTHORS: Videira, M ; Gaspar, R;
PUBLISHED: 2012, SOURCE: Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics
INDEXED IN: Scopus CrossRef
IN MY: ORCID
47
TITLE: Therapeutic products: Regulating drugs and medical devices
AUTHORS: Gaspar, RS;
PUBLISHED: 2010, SOURCE: International Handbook on Regulating Nanotechnologies
INDEXED IN: Scopus
IN MY: ORCID
48
TITLE: The regulatory landscape: implications for design and development of nanomedicines
AUTHORS: Gaspar, R;
PUBLISHED: 2009, SOURCE: JOURNAL OF PHARMACY AND PHARMACOLOGY, VOLUME: 61
INDEXED IN: WOS
50
TITLE: Antagonist G-mediated targeting and cytotoxicity of liposomal doxorubicin in NCl-H82 variant small cell lung cancer  Full Text
AUTHORS: Moreira, JN ; Gaspar, R;
PUBLISHED: 2004, SOURCE: BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, VOLUME: 37, ISSUE: 8
INDEXED IN: Scopus WOS
IN MY: ORCID
Page 5 of 8. Total results: 73.